Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cytokines
cytokines
Sanofi pays Synthekine $40M to join preclinical push against vexing inflammatory target
Fierce Biotech
Mon, 01/29/24 - 11:07 am
Sanofi
Synthekine
cytokines
inflammatory diseases
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Fierce Biotech
Fri, 07/28/23 - 10:44 am
Sanofi
BioNTech
MRNA
cytokines
cancer
Novartis-partnered Orionis secures $55M to push cytokine program into clinic
Endpoints
Wed, 10/19/22 - 10:55 am
Orionis Biosciences
Novartis
funding
R&D
cytokines
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
SITC
Incyte
ChemoCentryx
Amgen
cytokines
Cytokines claimed spotlight due to COVID-19. Now, Merck will work with Synthekine to understand their role in autoimmune disorders
Fierce Biotech
Mon, 11/1/21 - 10:56 am
Merck
cytokines
biobucks
Synthekine
drug development
Cytokine interest shows no sign of waning
EP Vantage
Thu, 08/26/21 - 10:45 am
cytokines
Nektar
Bristol Myers Squibb
Proleukin
Versant-backed Bright Peak sets a date to bring its IL-2 into the clinic — but all eyes are on an IPO after latest mega-round drops
Endpoints
Thu, 06/10/21 - 11:08 am
Bright Peak Therapeutics
Versant
IPOs
funding
cytokines
Evelo Biosciences' Potential COVID-19 Treatment Progresses into Phase II Study
BioSpace
Thu, 05/7/20 - 10:20 pm
Evelo Biosciences
clinical trials
cytokines
COVID-19
EDP1815
Chimerix starts Phase II/III trial of heparin-derived blood cancer drug in Covid-19
MedCity News
Sun, 05/3/20 - 08:02 pm
Chimerix
DSTAT
cytokines
clinical trials
COVID-19
pandemic
strokes
Heparin
Preclinical biotech Synthorx wants a $100M IPO
Fierce Biotech
Wed, 11/14/18 - 11:51 am
IPOs
biotech
Synthorx
immuno-oncology
cytokines
From Iran To CEO Of A Biotech Startup, Bioniz, With No Revenue But A $400 Million Valuation
Forbes
Wed, 12/20/17 - 10:47 am
biotech
Bioniz
Iran
cytokines